Jeff Hall

Emerging technology could provide key advances in pre-op planning and intraoperative management in endovascular surgery.

The iBreastExam, a handheld device cleared by the FDA, reportedly enhances routine clinical breast examinations.

While digital breast tomosynthesis is reportedly more effective at detecting cancer, new research suggests a higher recall rate due to fatigue and less experience in interpreting the images.

New research suggests an emerging machine learning model that combines findings from advanced imaging with clinical data may improve risk stratification in people with coronary artery disease.

Code for quantitative CT tissue characterization goes into effect on July 1.

Researchers found the use of magnetic resonance spectroscopic imaging revealed pathologic evidence of multiple sclerosis that is not evident on T1 or T2-weighted MRI.

Expanded MRI labeling for Abbott’s Proclaim™ XR Spinal Cord Stimulation System may facilitate increased efficiency and quality of MRI scans.

Will this artificial intelligence technology improve diagnostic accuracy and reduce false positive biopsy orders?

A new meta-analysis examines the diagnostic benefit of this emerging complementary modality.

Emerging research suggests that frontotemporal atrophy on magnetic resonance imaging may be a key finding for chronic traumatic encephalopathy (CTE).

Addition of late contrast enhancement (LCE) CT reportedly bolsters diagnostic rate for patients with acute chest pain who have negative findings on triple-rule-out (TRO) CT.

GE Healthcare unveils on-site detection upgrades and other advances with CT system as well as a new MRI device.